Cargando…

PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH

Detalles Bibliográficos
Autores principales: Sabljic, A., Sedinic, M., Kusec, R., Pejsa, V., Lucijanic, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429099/
http://dx.doi.org/10.1097/01.HS9.0000851340.65769.96
_version_ 1784779329147764736
author Sabljic, A.
Sedinic, M.
Kusec, R.
Pejsa, V.
Lucijanic, M.
author_facet Sabljic, A.
Sedinic, M.
Kusec, R.
Pejsa, V.
Lucijanic, M.
author_sort Sabljic, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9429099
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94290992022-08-31 PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH Sabljic, A. Sedinic, M. Kusec, R. Pejsa, V. Lucijanic, M. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429099/ http://dx.doi.org/10.1097/01.HS9.0000851340.65769.96 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Sabljic, A.
Sedinic, M.
Kusec, R.
Pejsa, V.
Lucijanic, M.
PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH
title PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH
title_full PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH
title_fullStr PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH
title_full_unstemmed PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH
title_short PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH
title_sort pb2127: no impact of statin use on response and survival rates in newly diagnosed dlbcl patients treated with r-da-epoch
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429099/
http://dx.doi.org/10.1097/01.HS9.0000851340.65769.96
work_keys_str_mv AT sabljica pb2127noimpactofstatinuseonresponseandsurvivalratesinnewlydiagnoseddlbclpatientstreatedwithrdaepoch
AT sedinicm pb2127noimpactofstatinuseonresponseandsurvivalratesinnewlydiagnoseddlbclpatientstreatedwithrdaepoch
AT kusecr pb2127noimpactofstatinuseonresponseandsurvivalratesinnewlydiagnoseddlbclpatientstreatedwithrdaepoch
AT pejsav pb2127noimpactofstatinuseonresponseandsurvivalratesinnewlydiagnoseddlbclpatientstreatedwithrdaepoch
AT lucijanicm pb2127noimpactofstatinuseonresponseandsurvivalratesinnewlydiagnoseddlbclpatientstreatedwithrdaepoch